SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001453687-24-000088
Filing Date
2024-06-17
Accepted
2024-06-17 07:54:40
Documents
13
Period of Report
2024-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20240614.htm   iXBRL 8-K 41466
  Complete submission text file 0001453687-24-000088.txt   168776

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240614.xsd EX-101.SCH 1981
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20240614_lab.xml EX-101.LAB 22788
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20240614_pre.xml EX-101.PRE 13107
16 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240614_htm.xml XML 2728
Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 241046977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)